期刊文献+

Recent advances in engineering iron oxide nanoparticles for effective magnetic resonance imaging 被引量:4

原文传递
导出
摘要 Iron oxide nanoparticle(IONP)with unique magnetic property and high biocompatibility have been widely used as magnetic resonance imaging(MRI)contrast agent(CA)for long time.However,a review which comprehensively summarizes the recent development of IONP as traditional T_(2) CA and its new application for different modality of MRI,such as T_(1) imaging,simultaneous T_(2)/T_(1) or MRI/other imaging modality,and as environment responsive CA is rare.This review starts with an investigation of direction on the development of high-performance MRI CA in both T_(2) and T_(1) modal based on quantum mechanical outer sphere and Solomon-Bloembergen-Morgan(SBM)theory.Recent rational attempts to increase the MRI contrast of IONP by adjusting the key parameters,including magnetization,size,effective radius,inhomogeneity of surrounding generated magnetic field,crystal phase,coordination number of water,electronic relaxation time,and surface modification are summarized.Besides the strategies to improve r2 or r1 values,strategies to increase the in vivo contrast efficiency of IONP have been reviewed from three different aspects,those are introducing second imaging modality to increase the imaging accuracy,endowing IONP with environment response capacity to elevate the signal difference between lesion and normal tissue,and optimizing the interface structure to improve the accumulation amount of IONP in lesion.This detailed review provides a deep understanding of recent researches on the development of high-performance IONP based MRI CAs.It is hoped to trigger deep thinking for design of next generation MRI CAs for early and accurate diagnosis.
出处 《Bioactive Materials》 SCIE 2022年第6期214-245,共32页 生物活性材料(英文)
基金 supported by the National Natural Science Foundation of China(81601607 and 81971609) Chongqing High-level Personnel of Special Support Program(Youth Top-notch Talent CQYC201905077) Creative Research Group of CQ University(CXQT21017).
  • 相关文献

二级参考文献35

  • 1Szakacs, G.; Paterson, J. K.; Ludwig, J. A.; Booth-Genthe, C.; Gottesman, M. M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006, 5, 219-234. 被引量:1
  • 2Kirkin, V.; Joos, S.; Zornig, M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta-Mol. Cell Res. 2004, 1644,229-249. 被引量:1
  • 3Kruh, G. D. Introduction to resistance to anticancer agents. Oncogene 2003, 22, 7262-7264. 被引量:1
  • 4Calderwood, S. K.; Khaleque, M. A.; Sawyer, D. B.; Ciocca, D. R. Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem. Sci. 2006,31, 164-172. 被引量:1
  • 5Duhem, C.; Ries, F.; Dicato, M. What does multidrug resistance (MDR) expression mean in the clinic. Oncologist 1996,1,151-158. 被引量:1
  • 6Krishna, R.; Mayer, L. D. Multidrug resistance (MDR) in cancer: Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 2000,11,265-283. 被引量:1
  • 7Ferry, D. R.; Traunecker, H.; Kerr, D. J. Clinical trials of P-gJycoprotein reversal in solid tumours. Eur. J. Cancer 1996, 32A, 1070-1081. 被引量:1
  • 8Rowinsky, E. K.; Smith, L.; Wang, Y. M.; Chaturvedi, P.; Villalona, M.; Campbell, E.; Aylesworth, C.; Eckhardt, S. G.; Hammond, L.; Kraynak, M., et al. Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDRI and MRP. J. Clin. Oncol. 1998,16,2964-2976. 被引量:1
  • 9Jabr-Milane, L. S.; van Vlerken, L. E.; Yadav, S.; Amiji, M. M. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev. 2008, 34, 592-602. 被引量:1
  • 10Moore, A.; Basilion, J. P.; Chiocca, E. A.; Weissleder, R. Measuring transferrin receptor gene expression by NMR imaging. Biochim. Biophys. Acta-Mol. Cell Res. 1998, 1402, 239-249. 被引量:1

共引文献10

同被引文献65

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部